Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Heart Rehabilitation in patients awaiting Open heart surgery targeting to prevent Complications and to improve Quality of life (Heart-ROCQ): study protocol for a prospective, randomised, open, blinded endpoint (PROBE) trial.

Hartog J, Blokzijl F, Dijkstra S, DeJongste MJL, Reneman MF, Dieperink W, van der Horst ICC, Fleer J, van der Woude LHV, van der Harst P, Mariani MA.

BMJ Open. 2019 Sep 18;9(9):e031738. doi: 10.1136/bmjopen-2019-031738.

2.

Treatment of resistant Raynaud's phenomenon with single-port thoracoscopic sympathicotomy: a novel minimally invasive endoscopic technique.

van Roon AM, Kuijpers M, van de Zande SC, Abdulle AE, van Roon AM, Bos R, Bouma W, Klinkenberg TJ, Bootsma H, DeJongste MJL, Mariani MA, Smit AJ, Mulder DJ.

Rheumatology (Oxford). 2019 Sep 16. pii: kez386. doi: 10.1093/rheumatology/kez386. [Epub ahead of print]

PMID:
31529103
3.

Neuromodulation for systolic heart failure: more than a placebo effect?

Maass AH, DeJongste MJ, van der Meer P.

Eur J Heart Fail. 2017 Mar;19(3):401-403. doi: 10.1002/ejhf.752. No abstract available.

4.

Single-port videoscopic splanchnotomy for palliation of refractory chronic pancreatitis.

Kuijpers M, Klinkenberg TJ, Bouma W, Beese U, DeJongste MJ, Mariani MA.

Interact Cardiovasc Thorac Surg. 2016 Apr;22(4):393-6. doi: 10.1093/icvts/ivv392. Epub 2016 Jan 20.

PMID:
26794601
5.

Determining the Feasibility of Spinal Cord Neuromodulation for the Treatment of Chronic Systolic Heart Failure: The DEFEAT-HF Study.

Zipes DP, Neuzil P, Theres H, Caraway D, Mann DL, Mannheimer C, Van Buren P, Linde C, Linderoth B, Kueffer F, Sarazin SA, DeJongste MJL; DEFEAT-HF Trial Investigators.

JACC Heart Fail. 2016 Feb;4(2):129-136. doi: 10.1016/j.jchf.2015.10.006. Epub 2015 Dec 9. Erratum in: JACC Heart Fail. 2018 Jun;6(6):542.

6.

Underestimated Prevalence of Chronic Heart Failure among the Elderly Residing in Care Homes in Aruba.

Stoutjesdijk E, Barents M, Brouns RM, DeJongste MJ, Besselink HJ, Cheng JD, Wever R, Muskiet FA.

West Indian Med J. 2014 Jul 3;63(6):610-5. doi: 10.7727/wimj.2013.277. Epub 2014 Nov 4.

7.

The role of neutrophil gelatinase associated lipocalin (NGAL) as biological constituent linking depression and cardiovascular disease.

Gouweleeuw L, Naudé PJ, Rots M, DeJongste MJ, Eisel UL, Schoemaker RG.

Brain Behav Immun. 2015 May;46:23-32. doi: 10.1016/j.bbi.2014.12.026. Epub 2015 Jan 7. Review.

PMID:
25576802
8.

Single-port one-stage bilateral thoracoscopic sympathicotomy for severe hyperhidrosis: prospective analysis of a standardized approach.

Kuijpers M, Klinkenberg TJ, Bouma W, DeJongste MJ, Mariani MA.

J Cardiothorac Surg. 2013 Nov 26;8:216. doi: 10.1186/1749-8090-8-216.

9.

To amuse the muse of the brain by heart.

Dejongste MJ.

Neth Heart J. 2013 Apr;21(4):181-2. doi: 10.1007/s12471-013-0387-x. No abstract available.

10.

Depression after myocardial infarction: TNF-α-induced alterations of the blood-brain barrier and its putative therapeutic implications.

Liu H, Luiten PG, Eisel UL, Dejongste MJ, Schoemaker RG.

Neurosci Biobehav Rev. 2013 May;37(4):561-72. doi: 10.1016/j.neubiorev.2013.02.004. Epub 2013 Feb 13. Review.

PMID:
23415700
11.

Electrical neuromodulation for patients with cardiac diseases.

De Decker K, Beese U, Staal MJ, Dejongste MJ.

Neth Heart J. 2013 Feb;21(2):91-4. doi: 10.1007/s12471-012-0356-9.

12.

Myopathy during statin therapy in the daily practice of an outpatient cardiology clinic: prevalence, predictors and relation with vitamin D.

Riphagen IJ, van der Veer E, Muskiet FA, DeJongste MJ.

Curr Med Res Opin. 2012 Jul;28(7):1247-52. doi: 10.1185/03007995.2012.702102. Epub 2012 Jun 28.

PMID:
22686958
13.

Subcutaneous electrical nerve stimulation: a feasible and new method for the treatment of patients with refractory angina.

Buiten MS, DeJongste MJ, Beese U, Kliphuis C, Durenkamp A, Staal MJ.

Neuromodulation. 2011 May-Jun;14(3):258-65; discussion 265. doi: 10.1111/j.1525-1403.2011.00355.x. Epub 2011 Apr 19.

PMID:
21992250
14.

Multimorbidity, the predominant predictor of quality-of-life, following successful spinal cord stimulation for angina pectoris.

Jitta DJ, DeJongste MJ, Kliphuis CM, Staal MJ.

Neuromodulation. 2011 Jan;14(1):13-8; discussion 18-9. doi: 10.1111/j.1525-1403.2010.00321.x. Epub 2010 Dec 13.

PMID:
21992156
15.

Neuromodulation for refractory angina: a Hedonic therapy?

Dejongste MJ.

Pain. 2011 Jan;152(1):6-7. doi: 10.1016/j.pain.2010.10.022. Epub 2010 Nov 26. No abstract available.

PMID:
21112700
16.

Basic research models for the study of underlying mechanisms of electrical neuromodulation and ischemic heart-brain interactions.

Dejongste MJ, Terhorst GJ, Foreman RD.

Cleve Clin J Med. 2009 Apr;76 Suppl 2:S41-6. doi: 10.3949/ccjm.76.s2.09. Review.

17.

Spinal cord stimulation in the treatment of refractory angina: systematic review and meta-analysis of randomised controlled trials.

Taylor RS, De Vries J, Buchser E, Dejongste MJ.

BMC Cardiovasc Disord. 2009 Mar 25;9:13. doi: 10.1186/1471-2261-9-13.

18.

Can spinal cord stimulation bail out Sisyphus' burden of sufferings?

DeJongste MJ, Taylor R.

Pain. 2008 Dec;140(3):397-8. doi: 10.1016/j.pain.2008.10.008. Epub 2008 Nov 11. No abstract available.

PMID:
19004547
19.

Long-term effects of electrical neurostimulation in patients with unstable angina: refractory to conventional therapies.

de Vries J, Dejongste MJ, Zijlstra F, Staal M.

Neuromodulation. 2007 Oct;10(4):345-8. doi: 10.1111/j.1525-1403.2007.00121.x.

PMID:
22150893
20.

The contribution of observational studies to the knowledge of drug effectiveness in heart failure.

Dobre D, van Veldhuisen DJ, DeJongste MJ, van Sonderen E, Klungel OH, Sanderman R, Ranchor AV, Haaijer-Ruskamp FM.

Br J Clin Pharmacol. 2007 Oct;64(4):406-14. Epub 2007 Aug 31. Review.

21.

Impact of electrical neurostimulation on persistent ST elevation after successful reperfusion by primary percutaneous coronary intervention.

de Vries J, Svilaas T, DeJongste MJ, Nieuwland W, Hoekstra-Mars EW, Zijlstra F.

J Electrocardiol. 2007 Nov-Dec;40(6):522-6. Epub 2007 Jul 13.

PMID:
17631890
22.

The effect of electrical neurostimulation on collateral perfusion during acute coronary occlusion.

de Vries J, Anthonio RL, Dejongste MJ, Jessurun GA, Tan ES, de Smet BJ, van den Heuvel AF, Staal MJ, Zijlstra F.

BMC Cardiovasc Disord. 2007 Jun 27;7:18.

23.

Incidence and angiographic predictors of collateral function in patients with stable coronary artery disease scheduled for percutaneous coronary intervention.

de Vries J, Anthonio RL, van den Heuvel AF, Tan ES, Jessurun GA, de Smet BJ, DeJongste MJ, Zijlstra F.

Catheter Cardiovasc Interv. 2007 Aug 1;70(2):197-202.

PMID:
17503495
24.

The anti-ischemic effects of electrical neurostimulation in the heart.

de Vries J, Foreman RD, DeJongste MJ.

Cleve Clin J Med. 2007 Feb;74 Suppl 1:S42-7. Review. No abstract available.

25.

Effectiveness of beta-blocker therapy in daily practice patients with advanced chronic heart failure; is there an effect-modification by age?

Dobre D, DeJongste MJ, Lucas C, Cleuren G, van Veldhuisen DJ, Ranchor AV, Haaijer-Ruskamp F.

Br J Clin Pharmacol. 2007 Mar;63(3):356-64. Epub 2006 Sep 12.

26.

Prescription of beta-blockers in patients with advanced heart failure and preserved left ventricular ejection fraction. Clinical implications and survival.

Dobre D, van Veldhuisen DJ, DeJongste MJ, Lucas C, Cleuren G, Sanderman R, Ranchor AV, Haaijer-Ruskamp FM.

Eur J Heart Fail. 2007 Mar;9(3):280-6. Epub 2006 Oct 5.

27.
28.

Preemptive, but not reactive, spinal cord stimulation mitigates transient ischemia-induced myocardial infarction via cardiac adrenergic neurons.

Southerland EM, Milhorn DM, Foreman RD, Linderoth B, DeJongste MJ, Armour JA, Subramanian V, Singh M, Singh K, Ardell JL.

Am J Physiol Heart Circ Physiol. 2007 Jan;292(1):H311-7. Epub 2006 Aug 18.

29.

The sustained benefits of long-term neurostimulation in patients with refractory chest pain and normal coronary arteries.

de Vries J, Dejongste MJ, Durenkamp A, Zijlstra F, Staal MJ.

Eur J Pain. 2007 Apr;11(3):360-5. Epub 2006 Jun 9.

PMID:
16762572
30.

An open label, single-centre, randomized trial of spinal cord stimulation vs. percutaneous myocardial laser revascularization in patients with refractory angina pectoris: the SPiRiT trial.

de Vries J, DeJongste MJ, Tio RA.

Eur Heart J. 2006 Jul;27(13):1631-2; author reply 1632. Epub 2006 Jun 2. No abstract available.

PMID:
16751209
31.

The effect of electrical neurostimulation on collateral perfusion.

de Vries J, Anthonio RL, DeJongste MJ, Jessurun GA, Tio RA, Zijlstra F.

Neth Heart J. 2006 Jun;14(6):209-214.

32.

Personality: predictor of neurostimulation outcomes in patients with chest pain and normal coronary arteries.

de Vries J, Dejongste MJ, Versteegen GJ, Durenkamp A, Staal MJ.

Neuromodulation. 2006 Apr;9(2):123-7. doi: 10.1111/j.1525-1403.2006.00057.x.

PMID:
22151636
33.

The effect of beta-blocker therapy on quality of life in heart failure patients: a systematic review and meta-analysis.

Dobre D, van Jaarsveld CH, deJongste MJ, Haaijer Ruskamp FM, Ranchor AV.

Pharmacoepidemiol Drug Saf. 2007 Feb;16(2):152-9. Review.

PMID:
16555368
34.

The relationship between self-efficacy and self-reported physical functioning in chronic obstructive pulmonary disease and chronic heart failure.

Arnold R, Ranchor AV, DeJongste MJ, Köeter GH, Ten Hacken NH, Aalbers R, Sanderman R.

Behav Med. 2005 Fall;31(3):107-15.

PMID:
16252622
35.

High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure.

Bruins S, Fokkema MR, Römer JW, Dejongste MJ, van der Dijs FP, van den Ouweland JM, Muskiet FA.

Clin Chem. 2004 Nov;50(11):2052-8. Epub 2004 Sep 2.

PMID:
15345664
36.

An integrated study of heart pain and behavior in freely moving rats (using fos as a marker for neuronal activation).

Albutaihi IA, DeJongste MJ, Ter Horst GJ.

Neurosignals. 2004 Sep-Oct;13(5):207-26.

37.

Chronic therapeutically refractory angina pectoris.

DeJongste MJ, Tio RA, Foreman RD.

Heart. 2004 Feb;90(2):225-30. Review. No abstract available.

38.
39.

Cardiac nociception in rats: neuronal pathways and the influence of dermal neurostimulation on conveyance to the central nervous system.

Albutaihi IA, Hautvast RW, DeJongste MJ, Ter Horst GJ, Staal MJ.

J Mol Neurosci. 2003 Feb;20(1):43-52.

PMID:
12663934
40.

Therapeutic options for patients with chronic refractory angina pectoris.

DeJongste MJ, Hautvast RW, Tio RA.

J Am Coll Cardiol. 2002 Oct 16;40(8):1541; author reply 1541-2. No abstract available.

41.

Cardiac tissue engineering: characteristics of in unison contracting two- and three-dimensional neonatal rat ventricle cell (co)-cultures.

van Luyn MJ, Tio RA, Gallego y van Seijen XJ, Plantinga JA, de Leij LF, DeJongste MJ, van Wachem PB.

Biomaterials. 2002 Dec;23(24):4793-801.

PMID:
12361618
42.

Long-term modulation of the intrinsic cardiac nervous system by spinal cord neurons in normal and ischaemic hearts.

Armour JA, Linderoth B, Arora RC, DeJongste MJ, Ardell JL, Kingma JG Jr, Hill M, Foreman RD.

Auton Neurosci. 2002 Jan 10;95(1-2):71-9.

PMID:
11873770
43.

Neuromodulation therapy does not influence blood flow distribution or left-ventricular dynamics during acute myocardial ischemia.

Kingma JG Jr, Linderoth B, Ardell JL, Armour JA, DeJongste MJ, Foreman RD.

Auton Neurosci. 2001 Aug 13;91(1-2):47-54.

PMID:
11515801
44.

The content and distribution of troponin I, troponin T, myoglobin, and alpha-hydroxybutyric acid dehydrogenase in the human heart.

Swaanenburg JC, Visser-VanBrummen PJ, DeJongste MJ, Tiebosch AT.

Am J Clin Pathol. 2001 May;115(5):770-7.

PMID:
11345843
45.

Modulation of intrinsic cardiac neurons by spinal cord stimulation: implications for its therapeutic use in angina pectoris.

Foreman RD, Linderoth B, Ardell JL, Barron KW, Chandler MJ, Hull SS Jr, TerHorst GJ, DeJongste MJ, Armour JA.

Cardiovasc Res. 2000 Aug;47(2):367-75.

PMID:
10946073
46.

Spinal cord stimulation for ischemic heart disease.

DeJongste MJ.

Neurol Res. 2000 Apr;22(3):293-8. Review.

PMID:
10769823
47.

Electrical neuromodulation for disabling angina pectoris related to isolated stenoses of small epicardial coronary arteries.

Jessurun GA, Hautvast RW, DeJongste MJ, Meyler WJ, van Boven AJ, Crijns HJ.

J Invasive Cardiol. 1999 Jul;11(7):435-8.

PMID:
10745568
48.

Clinical follow-up after cessation of chronic electrical neuromodulation in patients with severe coronary artery disease: a prospective randomized controlled study on putative involvement of sympathetic activity.

Jessurun GA, DeJongste MJ, Hautvast RW, Tio RA, Brouwer J, van Lelieveld S, Crijns HJ.

Pacing Clin Electrophysiol. 1999 Oct;22(10):1432-9.

PMID:
10588144
49.

Longer pre-hospital delay in acute myocardial infarction in women because of longer doctor decision time.

Bouma J, Broer J, Bleeker J, van Sonderen E, Meyboom-de Jong B, DeJongste MJ.

J Epidemiol Community Health. 1999 Aug;53(8):459-64.

50.

Efficacy, safety and mechanisms of spinal cord stimulation used as an additional therapy for patients suffering from chronic refractory angina pectoris.

Dejongste MJ.

Neuromodulation. 1999 Jul;2(3):188-92. doi: 10.1046/j.1525-1403.1999.00188.x. No abstract available.

PMID:
22151207

Supplemental Content

Loading ...
Support Center